Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value:
$258.66M
Total Bought:
$53.58M
Total Sold:
$9.74M
Net Transaction:
+$43.84M
Notable People:
Robert Lorne Hopfner, Peter Tuxen Bisgaard, Pivotal Bioventure Partners, Pivotal Partners Ltd
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Vaxcyte, Inc.(PCVX)1,372,4251,372,4250$49.43M$63.32M24.48%+$13.89M
Oculis Holding AG(OCS)2,300,7742,288,658-12,116$40.45M$45.70M17.67%+$5.26M
Arcutis Biotherapeutics, Inc.(ARQT)2,120,5081,366,624-753,884$39.97M$39.69M15.34%-$284.8K
Evommune, Inc.(EVMN)01,926,943+1,926,943$0$32.99M12.75%+$32.99M
Zenas BioPharma, Inc.(ZBIO)779,045591,991-187,054$17.29M$21.50M8.31%+$4.20M
Trevi Therapeutics, Inc.(TRVI)1,256,7821,256,7820$11.50M$15.73M6.08%+$4.24M
Immunome, Inc.(IMNM)502,512732,512+230,000$5.88M$15.73M6.08%+$9.85M
MapLight Therapeutics, Inc.(MPLT)0611,447+611,447$0$10.74M4.15%+$10.74M
BioAge Labs, Inc.(BIOA)653,374653,3740$3.84M$8.64M3.34%+$4.80M
Recursion Pharmaceuticals, Inc.CL A(RXRX)595,518595,5180$2.91M$2.44M0.94%-$470.5K
Rallybio Corporation(RLYB)2,404,6442,404,6440$1.20M$1.65M0.64%+$449.7K
Bolt Biotherapeutics Inc94,57394,5730$503.1K$517.1K0.20%+$14.0K
Page 1 of 1